Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Breast Cancer 2024

Current roles of novel endocrine therapies in the early and late settings

Implementation of novel endocrine therapies and combinations in the metastatic setting

Date

17 May 2024

Session

Current roles of novel endocrine therapies in the early and late settings

Topics

Tumour Site

Breast Cancer

Presenters

Philippe Aftimos

Authors

P.G. Aftimos

Author affiliations

  • Institute Jules Bordet, Anderlecht/BE

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A and discussion

Session: Current roles of novel endocrine therapies in the early and late settings

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.